Allarity Therapeutics, INC. (ALLR) SEC Filings — 2024
48 SEC filings for Allarity Therapeutics, INC. (ALLR) in 2024.
Filings
- Allarity Therapeutics Files 8-K — 8-K · Nov 19, 2024
- Allarity Therapeutics Q3 2024: Minimal Revenue, High Expenses — 10-Q · Nov 14, 2024
- Allarity Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
- Allarity Therapeutics Files 8-K — 8-K · Oct 23, 2024
- Allarity Therapeutics Files 8-K — 8-K · Oct 11, 2024
- Allarity Therapeutics Announces Executive and Board Changes — 8-K · Oct 4, 2024
- Allarity Therapeutics Files 8-K — 8-K · Sep 17, 2024
- Allarity Therapeutics Appoints New CMO, Adds Directors — 8-K · Sep 13, 2024
- Allarity Therapeutics Files 8-K Amendment — 8-K/A · Sep 10, 2024
- Allarity Therapeutics Reports Key Corporate Changes — 8-K · Sep 9, 2024
- Allarity Therapeutics, INC. SC 13G Filing — SC 13G · Aug 29, 2024
- Allarity Therapeutics Files 8-K: Material Agreements & Security Holder Changes — 8-K · Aug 21, 2024
- Allarity Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 5, 2024
- Allarity Therapeutics Files Proxy Statement Supplement — DEFA14A · Jul 26, 2024
- Allarity Therapeutics Files 8-K Report — 8-K · Jul 23, 2024
- Allarity Therapeutics to be Acquired by 1450 LLC — 8-K · Jul 22, 2024
- Allarity Therapeutics Files Proxy Statement for July 26 Meeting — DEF 14A · Jul 1, 2024
- Allarity Therapeutics Files 8-K — 8-K · Jun 28, 2024
- Allarity Therapeutics Files 8-K Report — 8-K · Jun 26, 2024
- Allarity Therapeutics Faces Delisting Concerns — 8-K · Jun 21, 2024
- Allarity Therapeutics Files 8-K on Officer/Director Changes — 8-K · Jun 6, 2024
- Allarity Therapeutics Files 8-K Amendment — 8-K/A · May 24, 2024
- Allarity Therapeutics Files 8-K: Material Agreement — 8-K · May 21, 2024
- Allarity Therapeutics Files 8-K on Financials — 8-K · May 15, 2024
- Allarity Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- Allarity Therapeutics Files Current Report — 8-K · May 9, 2024
- Allarity Therapeutics Files 8-K — 8-K · May 6, 2024
- Allarity Therapeutics Files 8-K — 8-K · May 3, 2024
- Allarity Therapeutics Files 8-K Current Report — 8-K · Apr 30, 2024
- Allarity Therapeutics Files Amendment to Annual Report — 10-K/A · Apr 29, 2024
- Allarity Therapeutics Files 8-K — 8-K · Apr 18, 2024
- Allarity Therapeutics Files Amendment 5 to S-1 Registration Statement — S-1/A · Apr 17, 2024
- Allarity Therapeutics Files Amendment to S-1 Registration Statement — S-1/A · Apr 8, 2024
- Aptose Biosciences to Acquire Allarity Therapeutics — 8-K · Apr 5, 2024
- Allarity Therapeutics Merges with Egetis, Renamed Egetis Therapeutics — 8-K · Apr 4, 2024
- Allarity Therapeutics Files 8-K — 8-K · Apr 1, 2024
- Allarity Therapeutics Files 8-K — 8-K · Mar 26, 2024
- Allarity Therapeutics Files 8-K — 8-K · Mar 20, 2024
- Allarity Therapeutics Sells $1M in Stock — 8-K · Mar 15, 2024
- Allarity Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 8, 2024
- Allarity Therapeutics Announces Special Meeting of Stockholders on April 1, 2024 — DEF 14A · Mar 8, 2024
- Allarity Therapeutics Board Changes — 8-K · Mar 4, 2024
- Allarity Therapeutics Files 8-K with Material Agreement — 8-K · Mar 1, 2024
- Allarity Reports Material Agreements, New Debt, Equity Sales — 8-K · Feb 14, 2024
- 3i, LP Amends Allarity Therapeutics Stake to 653,377 Shares — SC 13G/A · Feb 12, 2024
- Allarity Terminates Dovitinib Agreement with Oncoheroes — 8-K · Feb 1, 2024
- Allarity Therapeutics Files 8-K on Material Agreement — 8-K · Jan 25, 2024
- Allarity Therapeutics: Material Agreements, Equity Sales, Bylaw Changes — 8-K · Jan 19, 2024